Immunovant Statistics Share Statistics Immunovant has 174.32M
shares outstanding. The number of shares has increased by 16.78%
in one year.
Shares Outstanding 174.32M Shares Change (YoY) 16.78% Shares Change (QoQ) 0.63% Owned by Institutions (%) 63.21% Shares Floating 70.59M Failed to Deliver (FTD) Shares 42 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 16.07M, so 9.22% of the outstanding
shares have been sold short.
Short Interest 16.07M Short % of Shares Out 9.22% Short % of Float 26.88% Short Ratio (days to cover) 14.16
Valuation Ratios The PE ratio is -6.26 and the forward
PE ratio is -5.7.
Immunovant's PEG ratio is
-0.14.
PE Ratio -6.26 Forward PE -5.7 PS Ratio 0 Forward PS 272.5 PB Ratio 3.66 P/FCF Ratio -6.88 PEG Ratio -0.14
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Immunovant.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 11.16,
with a Debt / Equity ratio of 0.
Current Ratio 11.16 Quick Ratio 11.16 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.14M Employee Count 362 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 891K Effective Tax Rate -0.22%
Stock Price Statistics The stock price has increased by -44.82% in the
last 52 weeks. The beta is 0.44, so Immunovant's
price volatility has been higher than the market average.
Beta 0.44 52-Week Price Change -44.82% 50-Day Moving Average 16.34 200-Day Moving Average 18.88 Relative Strength Index (RSI) 54.9 Average Volume (20 Days) 1,613,728
Income Statement
Revenue n/a Gross Profit -377K Operating Income -438.15M Net Income -413.84M EBITDA -412.57M EBIT -412.95M Earnings Per Share (EPS) -2.73
Full Income Statement Balance Sheet The company has 713.97M in cash and 98K in
debt, giving a net cash position of 713.87M.
Cash & Cash Equivalents 713.97M Total Debt 98K Net Cash 713.87M Retained Earnings -1.24B Total Assets 661.44M Working Capital 598.86M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -375.87M
and capital expenditures -759K, giving a free cash flow of -376.63M.
Operating Cash Flow -375.87M Capital Expenditures -759K Free Cash Flow -376.63M FCF Per Share -2.48
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
